Get started
Eyenovia, Inc.Eyenovia, Inc.Eyenovia, Inc.

Eyenovia, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

EYEN chart


Full chart

EYEN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.15 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.7313 USD
Net income (FY)
‪−27.26 M‬ USD
Revenue (FY)
‪3.79 K‬ USD
Shares float
‪109.77 M‬
Beta (1Y)
1.65

Employees


Employees (FY)
57
Change (1Y)
+16 +39.02%
Revenue / Employee (1Y)
66.44 USD
Net income / Employee (1Y)
‪−478.26 K‬ USD

About Eyenovia, Inc.


Sector
Health Technology
CEO
Michael M. Rowe
Headquarters
New York
Website
eyenovia.com
Founded
2014
FIGI
BBG00JKZRCH4
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EYEN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EYEN is 0.0349 USD — it has decreased by −34.74% in the past 24 hours. Watch Eyenovia, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eyenovia, Inc. stocks are traded under the ticker EYEN.
EYEN stock has fallen by −38.00% compared to the previous week, the month change is a −60.43% fall, over the last year Eyenovia, Inc. has showed a −98.20% decrease.
We've gathered analysts' opinions on Eyenovia, Inc. future price: according to them, EYEN price has a max estimate of 2.00 USD and a min estimate of 2.00 USD. Watch EYEN chart and read a more detailed Eyenovia, Inc. stock forecast: see what analysts think of Eyenovia, Inc. and suggest that you do with its stocks.
EYEN reached its all-time high on Jan 25, 2018 with the price of 10.7400 USD, and its all-time low was 0.0522 USD and was reached on Jan 23, 2025. View more price dynamics on EYEN chart.
See other stocks reaching their highest and lowest prices.
EYEN stock is 16.98% volatile and has beta coefficient of 1.65. Track Eyenovia, Inc. stock price on the chart and check out the list of the most volatile stocks — is Eyenovia, Inc. there?
Today Eyenovia, Inc. has the market capitalization of ‪4.15 M‬, it has increased by 2.70% over the last week.
Yes, you can track Eyenovia, Inc. financials in yearly and quarterly reports right on TradingView.
Eyenovia, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
EYEN earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.13 USD resulting in a 12.40% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Eyenovia, Inc. earnings.
Eyenovia, Inc. revenue for the last quarter amounts to ‪1.63 K‬ USD, despite the estimated figure of ‪153.10 K‬ USD. In the next quarter, revenue is expected to reach ‪1.60 M‬ USD.
EYEN net income for the last quarter is ‪−7.89 M‬ USD, while the quarter before that showed ‪−11.05 M‬ USD of net income which accounts for 28.64% change. Track more Eyenovia, Inc. financial stats to get the full picture.
No, EYEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 31, 2025, the company has 57.00 employees. See our rating of the largest employees — is Eyenovia, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eyenovia, Inc. EBITDA is ‪−30.70 M‬ USD, and current EBITDA margin is ‪−650.20 K‬%. See more stats in Eyenovia, Inc. financial statements.
Like other stocks, EYEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eyenovia, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eyenovia, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eyenovia, Inc. stock shows the sell signal. See more of Eyenovia, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.